Parsons Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,705
| Closed | -$276K | – | 426 |
|
|
2021
Q2 | $276K | Hold |
1,705
| – | – | 0.02% | 374 |
|
|
2021
Q1 | $208K | Hold |
1,705
| – | – | 0.02% | 397 |
|
|
2020
Q4 | $261K | Sell |
1,705
-1,395
| -45% | -$214K | 0.02% | 337 |
|
|
2020
Q3 | $259K | Hold |
3,100
| – | – | 0.03% | 310 |
|
|
2020
Q2 | $228K | Buy |
+3,100
| New | +$228K | 0.02% | 313 |
|
|
2018
Q3 | – | Sell |
-4,130
| Closed | -$243K | – | 359 |
|
|
2018
Q2 | $243K | Buy |
+4,130
| New | +$243K | 0.03% | 326 |
|